Stay updated on Pembrolizumab in mHSPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mHSPC Clinical Trial page.

Latest updates to the Pembrolizumab in mHSPC Clinical Trial page
- Check3 days agoChange DetectedThe page adds a site-wide notice about potential delays due to a lapse in government funding and updates the revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.7%

- Check10 days agoChange DetectedUI improvements include a Show glossary option and color-coded highlights for additions (green) and deletions (red). The page also updates revision/version information and removes the No FEAR Act Data notice.SummaryDifference0.9%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the study's version history.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.3.3 was added to the page history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. These updates are minor footer/navigation changes and do not affect core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check68 days agoChange DetectedThe history now includes a new revision entry 'Revision: v3.3.2' and removes the previous 'Revision: v3.3.1' from the list.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed on the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in mHSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mHSPC Clinical Trial page.